They showed that the trypsin inhibitor induced necrosis in tumour tissue, simultaneously suppressing the expression of pivotal genes associated with angiogenesis, such as matrix metalloproteinase genes (MMP-2, MMP-9) and vascular endothelial growth factor (VEGF). The gene discussed is MMP2; the disease is neoplasm.